Steven J. Katz, MD, MPH, discusses the benefits and challenges with genetic testing in patients with breast cancer.
Steven J. Katz, MD, MPH, professor of medicine and health management and policy at the University of Michigan, discusses the benefits and challenges with genetic testing in patients with breast cancer.
By identifying more genetic mutations in a patient, there is more understanding of the patient’s risk, says Katz. These pathogenic mutations and variances can be helpful in considering risk of cancer for both the patient and their family.
Analyzing ADC Treatment Sequencing in Advanced Breast Cancer
March 15th 2024In the first article of a 2-part series, Virginia G. Kaklamani, MD, discussed her approach to biomarker testing and treatment sequencing for patients with hormone receptor–positive, HER2-negative metastatic breast cancer.
Read More
Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss
September 25th 2020In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion.
Listen